- Home
- AQMS vs KTTA Comparison
AQMS vs KTTA Comparison
Compare AQMS & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQMS
- KTTA
- Stock Information
- Founded
- AQMS 2014
- KTTA 2020
- Country
- AQMS United States
- KTTA United States
- Employees
- AQMS N/A
- KTTA N/A
- Industry
- AQMS Metal Fabrications
- KTTA Biotechnology: Pharmaceutical Preparations
- Sector
- AQMS Industrials
- KTTA Health Care
- Exchange
- AQMS Nasdaq
- KTTA Nasdaq
- Market Cap
- AQMS 5.5M
- KTTA 5.5M
- IPO Year
- AQMS 2015
- KTTA 2021
- Fundamental
- Price
- AQMS $0.53
- KTTA $0.69
- Analyst Decision
- AQMS Strong Buy
- KTTA
- Analyst Count
- AQMS 3
- KTTA 0
- Target Price
- AQMS $21.00
- KTTA N/A
- AVG Volume (30 Days)
- AQMS 6.3M
- KTTA 136.4K
- Earning Date
- AQMS 08-04-2025
- KTTA 08-12-2025
- Dividend Yield
- AQMS N/A
- KTTA N/A
- EPS Growth
- AQMS N/A
- KTTA N/A
- EPS
- AQMS N/A
- KTTA N/A
- Revenue
- AQMS N/A
- KTTA N/A
- Revenue This Year
- AQMS N/A
- KTTA N/A
- Revenue Next Year
- AQMS $550.00
- KTTA N/A
- P/E Ratio
- AQMS N/A
- KTTA N/A
- Revenue Growth
- AQMS N/A
- KTTA N/A
- 52 Week Low
- AQMS $0.47
- KTTA $0.67
- 52 Week High
- AQMS $7.80
- KTTA $7.50
- Technical
- Relative Strength Index (RSI)
- AQMS 36.08
- KTTA 32.71
- Support Level
- AQMS $0.47
- KTTA $0.67
- Resistance Level
- AQMS $1.02
- KTTA $0.77
- Average True Range (ATR)
- AQMS 0.09
- KTTA 0.03
- MACD
- AQMS 0.01
- KTTA 0.01
- Stochastic Oscillator
- AQMS 6.58
- KTTA 22.68
About AQMS Aqua Metals Inc.
Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting, and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).